Enterprise-wide license to Strainprint Analytics, Clinic Edition, will provide unparalleled medical cannabis treatment guidance.
For those aged 50 and older, men edged out women with respect to reporting efficacy of top-treated symptoms.
Have a listen to our Co-Founder & Chief Creative Officer, Stephanie Karasick as she interviews alongside Dr. Danial Schecter on the Alternative Food Network podcast on the Health Effects of Cannabis.
Michelle Arbus joined Business of Cannabis to talk about how the data that she will be presenting identifies trends among older cannabis users and what that means for medical cannabis patients.
CEO’s Journey with Cannabis Helps Community “Use Cannabis Better”
Strainprint Technologies Ltd. Continues Rapid Growth, Welcoming Two New Senior Staff Members to the Expanding Team TORONTO, August 01, 2018 – Strainprint Technologies Ltd. (Strainprint™) – the leader in cannabis strain data and analytics – is excited to announce the addition of two key senior team members: Michelle Arbus, Vice President of Research & Insights, […]
Strainprint Featured In The Green Market Report – Big Data Opens A New Path for Cannabis Patients Strainprint is leading the way in the cannabis industry with its rich and robust medical patient data and sophisticated Business Intelligence solutions. With a vision to advance the scientific understanding of cannabis and its legitimization as a therapy […]
Anxiety And Stress Scientifically Proven To Be Reduced By Cannabis